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Abstract: There are several avenues by which promising bioactive natural products can be 
produced in sufficient quantities to enable lead optimization and medicinal chemistry 
studies. The total synthesis of natural products is an important, but sometimes difficult, 
approach and requires the development of innovative synthetic methodologies to simplify 
the synthesis of complex molecules. Various classes of natural product alkaloids are both 
common and widely distributed in plants, bacteria, fungi, insects and marine organisms. 
This mini-review will discuss the scope, mechanistic insights and enantioselectivity aspects 
of selected examples of recently developed one-pot methods that have been published in 
2009 for the synthesis of substituted piperidines, quinolizidines, pyrrolidines, 
hexahydropyrrolizines, octahydroindolizines and γ-lactams. In addition, progress on the 
synthesis of β-carboline (manzamine) alkaloids will also be discussed. 
Keywords:  one-pot synthesis; cascade reactions; marine alkaloids; total synthesis; 
semisynthesis; organocatalysis 
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1. Introduction 
The challenging task of developing a drug candidate from a natural source to clinical usage has 
many obstacles. Toxicity, development of resistance associated with the drug candidate, and providing 
a sufficient amount of material needed for preclinical and clinical studies, all represent major 
challenges. Although nature has been generous in providing structurally diverse molecules with 
varying biological activities, it is not always possible to obtain the required quantities of the desired 
drug candidate. This lack of material has inspired innovative chemistry that develops new 
methodologies, catalysts and inventive synthetic routes for the synthesis and modification of 
natural products. 
Our research program has been involved in the isolation and the optimization process of a number 
of marine alkaloids and peptides. Among the most intriguing is manzamine A (1) with impressive 
antimalarial activity. A number of chemical stability challenges associated with its chemical 
modification require significant attention due to the complexity of the structure. This compound can be 
easily isolated from a marine sponge in good yields [1]. This inspired the development of new one-pot 
synthetic methodologies and conditions which are applicable to 1 and to other bioactive 
natural products.  
During lead optimization of the manzamine alkaloids, the importance of one-pot methods for 
scaling certain drug leads became apparent. One-pot reactions are reactions in which two or more 
bond-forming transformations take place under the same reaction conditions without adding additional 
reagents or catalysts [2]. These reactions have numerous applications in the field of total synthesis of 
natural products, particularly in avoiding the costly protection/deprotection processes and purification 
of intermediates [2–6]. The importance of these reactions to the organic synthesis community is 
illustrated by the numerous reviews that have discussed different aspects of these reactions [2–11]. 
Most of these reviews discuss one-pot reactions that were developed during the total synthesis of 
selected examples of natural products (either as designed or serendipitous developments) such as 
Nicolaou’s [4–6] and Tietze’s reviews [2,3]. Although outstanding one-pot transformations designed 
for total synthesis of natural products were highlighted in these reviews, other one-pot transformations 
designed for other purposes were omitted. Synthesis of heterocycles by one-pot methodologies were 
discussed in detail in Padwa’s reviews [9,10]. Specific reviews on the construction of alkaloids are not 
found with the exception of Kobayashi’s review that discussed new methodologies developed for the 
total synthesis of some select examples of alkaloids [11]. 
Due to the growing interest in marine alkaloids, a detailed discussion of select, newly developed 
one-pot methodologies that have been utilized for the modification of marine alkaloids or the synthesis 
of common alkaloid moieties emphasizing asymmetric synthesis, are presented here. This mini-review 
discusses applications, mechanistic insights and enantioselectivity of recently developed one-pot 
methods that have been published during 2009. Those reports that could be applied in the synthesis of 
marine alkaloid scaffolds (i.e., alkaloid moieties found in marine alkaloids) are emphasized. This 
mini-review will also cover our results for the manzamine alkaloids, as well as detailed asymmetric 
one-pot methods for the synthesis of substituted piperidines, quinolizidines, pyrrolidines, 
hexahydropyrrolizines, octahydroindolizines and γ-lactams. 
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2. New One-Pot Methods Used in the Modification of Marine Alkaloids 
One-pot reductive amidation of nitroarenes 
Manzamine alkaloids are a unique class of compounds that contain a complicated ring system 
coupled with a β-carboline moiety (Figure 1). The first representative of this family is 
manzamine A (1), which was first isolated by Higa and co-workers in 1986 [11]. This class of 
alkaloids has shown a wide range of biological activities (antimicrobial, antiparasitic, cytotoxicity, 
anti-inflammatory and pesticidal) and has also shown activity against HIV-1 and AIDS opportunistic 
infections [12]. The most potent activity for the manzamine alkaloids appears to be against malaria. 
Manzamine A (1) and its natural analog 8-hydroxymanzamine A (2) exhibited improved potency 
against malarial parasites both in vitro and in vivo relative to chloroquine and artemisinin [13]. 
However, the toxicity associated with high dose schedules limited the development of this class of 
compounds as new antimalarial drugs. 
Figure 1. Manzamine alkaloids. 
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Since the mechanism of action of manzamine alkaloids as antimalarial agents is not completely 
clear; several structure activity relationship SAR and optimization studies using 1, 2 or 3 as starting 
materials have been completed [14–18]. Nitration of 1 yielded 6 and 8 nitromanzamines and after 
reduction afforded the corresponding aminomanzamines (Scheme 1). Aminomanzamines are not 
stable, making them unsuitable for further amidation and N-alkylation reactions. However, 20 amide 
analogs were successfully synthesized in very low yield [15]. 
Scheme 1. Nitration of manzamine A. 
6
8
N
N
N
OH
N
H H 1)  1.6 eq. NaNO2/TFA
2) Zn/AcOH/MeOH
3) Conc. HCl
6
N
N
N
OH
N
H H
R
H H
N
N
N
OH
N
H H
H
+
R
8
(5); R=NO2
(7); R=NH2
(6); R=NO2
(8); R=NH2  Mar. Drugs 2010, 8  
 
 
2398
Inspired by the instability of aminomanzamines (7 and 8) and by the low yields of the amide 
derivatives, a one-pot reductive amidation method was developed for the conversion of nitroarenes to 
the corresponding amides [19]. The reduction of the nitro group generally requires a protic solvent as a 
carrier of the hydrogen generated in situ. However, the amidation reaction using acyl chloride requires 
aprotic solvents as well as dry conditions to prevent side reactions with the solvent. In addition, the 
amidation reaction using acyl chlorides requires basic conditions in which the base will neutralize the 
hydrochloric acid liberated from the reaction as a by-product. Because of this, a 3
o amine base 
(triethylamine, Et3N) was added in the reduction step where equimolecular amounts of acetic acid and 
zinc are used in addition to the acyl chloride. Once the amine is formed in situ, it immediately reacted 
with the acyl chloride facilitated by the tertiary amine present. Dimethylformamide DMF was shown 
to be the best choice of solvent for this reaction (Scheme 2). Using the optimized conditions, several 
nitroarenes were screened for one-pot conversion to amides. All the reagents were added at once and 
complete conversion of the starting materials to the corresponding amines and amides was observed 
with ~60% yield of the amides. 
Scheme 2. Optimized one-pot conditions for the reductive amidation of nitroarenes. 
NO2 NH2 HN
+ 2 eq. Zn/ 4 eq. AcOH
DMF / 1.3 eq, R1COCl
2 eq. Et3N, 40 oC
O
R R
One-pot
~ 60%
R1
R
 
As a validation of this method, a one-pot approach was used for the synthesis of 
6-cyclohexamidomanzamine A (9). This amide derivative showed potent antimalarial activity in vitro 
with an IC50 of 0.032 μM against the D6 clone of Plasmodium falciparum, and was synthesized from 
6-aminomanzamine A (7) through the normal amidation pathway with low yield (17%)[15]. Starting 
with 6-nitromanzamine A (5), and using the optimized one-pot reductive amidation method, the yield 
of amide analog 9 was increased to 56% relative to 17% (Scheme 3). It was surprising that the 
reductive amidation of 5 proceeded without the addition of a 3
o amine base. A reasonable explanation 
for this observation is that 5 has two 3
o amine built-in bases which could possibly facilitate the 
reductive amidation reaction. To validate this explanation, harmane was nitrated to produce the closely 
related model compounds, 6- and 8- nitroharmanes. When the optimized one-pot reductive amidation 
conditions were applied to nitroharmanes without the addition of the Et3N, no amides were obtained, 
only aminoharmanes (Scheme 4, Equation 1); However, by adding Et3N the amide derivatives of 
harmane were isolated in good yield (60%)(Scheme 4, Equation 2). These experimental results 
validated the hypothesis regarding the built-in 3
o amine bases in manzamine alkaloids. 
Although this method was developed particularly for the modification of manzamine alkaloids, it 
has clear utility in the synthesis of other alkaloids. The nitration of several biologically active natural 
products, as well as currently utilized drugs to generate the starting nitro materials for this one-pot 
reductive amidation method is ongoing. The goal is to show the general and practical applications for Mar. Drugs 2010, 8  
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this method, as well as generating a library of compounds for further optimization and 
biological evaluation. 
Scheme 3. Synthesis of 6-cyclohexamidomanzamine A (9) by direct and reductive 
amidation approaches. Method A: 1.2 eq. cyclohexylcarbonyl chloride, 1.1 eq. Et3N, cat. 
DMAP, THF, rt, 1 h; Method B: 2 eq. Zn/4 eq. AcOH, 2 eq. Et3N, 1.2 eq. 
cyclohexylcarbonyl chloride, DMF, 40 °C, one-pot. 
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Scheme 4. Validation of the built-in 3
o amine bases in manzamine A using nitro harmane 
as model compounds. 
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3. New One-Pot Reactions Used in the Asymmetric Construction of Some Important Alkaloid Moieties 
3.1. One-pot asymmetric synthesis of substituted piperidines 
Piperidine containing alkaloids are common in marine environments [20–22]. Although there have 
been several synthetic methods [23–25] reported for construction of this moiety, stereoselectivity 
remains a challenging task especially when three or more stereogenic centers or quaternary substituted 
carbons are present. The Shi group developed a novel cascade approach for the stereoselective 
synthesis of the piperidine moiety, based on their development of an intermolecular   
cross-double-Michael addition between α,β-unsaturated carbonyl compounds and nitroalkenes, 
facilitated by amines as Lewis bases (LB)[26]. Allylic nitro products are generated in the process via Mar. Drugs 2010, 8  
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the β-elimination of the LB (Figure 2). The new cascade reaction encouraged Shi’s group to extend the 
cascade by involving an activated electrophilic intermediate for the construction of nitrogen containing 
heterocycles with two or more stereogenic centers. 
Figure 2. Intermolecular cross-double-Michael addition facilitated by amines via β-elimination. 
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Based on their previous results, which showed that the addition of the amine to nitroalkene is fast, 
they proposed a one-pot cascade approach for the asymmetric synthesis of the piperidine moiety [27]. 
They postulated that adduct A (Figure 3), the addition product of the amine with nitroalkene, was 
suitable for Michael addition type reaction with an activated carbonyl to generate adduct B. Ring 
closure then provides the substituted piperidine motif in a one-pot approach with the generation of 
three stereogenic centers. To validate this proposed one-pot cascade sequence, nitrostyrene was 
allowed to react with methyl vinyl ketone (MVK) in the presence of a primary amine (Scheme 5). 
Being a complex mixture with many possible side reactions (i.e., Baylis-Hillman reaction), it was 
surprising that substituted piperidines, 13a and 13b, were obtained in excellent yields and good 
diastereoselectivities with no side products. Solvent optimization of these one-pot conditions showed 
that THF gave the best yields with good diastereoselectivities (97%, dr = 7:1 for 13a; 85%, dr = 15:1 
for 13b). The formation of 13 confirmed the formation of adduct B (Figure 3), which was trapped by a 
sequential Henry-aldol cyclization. Although three stereogenic centers were generated in piperidine 13 
only two C-4 diastereoisomers were obtained, of which the cis isomer of C-3 nitro and C-4 hydroxy 
groups was the major product. 
Figure 3. Proposed one-pot cascade piperidine synthesis. 
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Scheme 5. Optimized one-pot condensation for the asymmetric synthesis of piperidine moiety. 
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This one-pot reaction was compatible with a variety of nitroalkenes, amines and activated 
carbonyls. Different aryl and alkyl substituted nitroalkenes generated variation at the C-2 position. Mar. Drugs 2010, 8  
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Moreover, both alkyl and aryl ketones were suitable for this cascade one-pot process giving different 
choices of substitutes on the C-4 position. Substituents on C-5 were possible through α-substituted 
enones, while β-substituted enones delivered variation at the C-6 position only when ammonia was 
used. It is interesting that only C-4 isomers were obtained in all cases.  
The aza-Michael adduct B (Figure 3) was not observed in reaction NMR studies; moreover, the 
piperidine products were stable under strong basic conditions. These results strongly suggested that the 
irreversible Henry-aldol cyclization was the rate determining step, which accounts for the piperidine 
diastereoselectivity through the chair transition state. With the formation of the C-2 stereogenic center 
during the amine conjugate addition, it is possible that the stereochemistry of the final piperidine 
product could be selectively induced by chiral amines through its involvement in the spatial 
arrangement of the chair transition state. In this case, a new stereogenic center on the exocyclic C-7 
will be introduced on the piperidine product, which may result in the formation of four 
diastereoisomers. To investigate this proposed chirality induction, arylethanamines 14a–c were applied 
in the one-pot piperidine synthesis and as expected, piperidines 15a–c were obtained in good yields 
(Scheme 6). The results showed excellent diastereoselectivity of the C-4 position in 15a and 15b with 
dr > 10:1. In addition, modest chirality induction by the C-7 position was observed with dr = 4:1. 
Scheme 6. Chirality induction by chiral amines. 
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X-ray analysis of the piperidine crystals revealed that the exocyclic C-7 adopted a staggered 
conformation with respect to the ring. Moreover, the chemical shifts of the C-8 and C-9 carbons were 
significantly shifted upfield in an anti-parallel position relative to the nitrogen lone pair electrons. This 
data suggest that the N1-C7 σ-bond rotation was restricted. Based on these results, a Henry-aldol 
cyclization chair transition state was proposed in Figure 4. The N-1 nitrogen lone pair electrons were 
placed in the axial position and the preferred staggered N1-C7 conformation could be achieved when 
the small group on C-7 was placed anti (axial orientation) to the N-1 nitrogen lone pair. Three   
syn-pentane interactions were expected in this staggered conformation (as shown in Figure 4); 
however, placement of the small group on C-7 anti to the lone pair will minimize these interactions. Mar. Drugs 2010, 8  
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This proposed transition state was consistent with experimental observations. Also, the stability of this 
transition state could be influenced by the n-σ* electronic interaction between the nitrogen lone pair 
and the exocyclic axial small group. 
Figure 4. Proposed chair transition state and the exocyclic chirality induction. 
 
To validate the importance of this n-σ* electronic interaction in the chirality enhancement, the 
methyl group was replaced in the chiral amine with a carboxylate group which is less bulky and would 
produce a stronger n-σ* interaction. As expected, the reaction of the amino esters 16a, b with enone 
12a and nitroarene 10a yielded the corresponding piperidine products in moderate yields (Scheme 7). 
Interestingly, piperidines 17a, b  were obtained in their diastereomerically pure form. Complete 
chirality induction was achieved through control via exocyclic asymmetry. This new one-pot method 
opens the door for the asymmetric synthesis of several natural products that contain a piperidine moiety. 
Scheme 7. Enhanced exocyclic stereochemistry control by amino esters. 
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3.2. One-pot organo-catalytic synthesis of quinolizidine derivatives 
An elegant one-pot method was developed recently by Franzen and Fisher [28] for the asymmetric 
synthesis of substituted quinolizidines. This moiety is widely represented in several alkaloids isolated 
from plants, ants and marine organisms. Their retrosynthetic analysis for the indolo[2,3a]quinolizidine 
skeleton is highlighted in Figure 5. They postulated that the stereogenic center 11b could be generated 
through the asymmetric acyliminium ion cyclization of the imine (19). This imine could be obtained 
upfield NMR shift, shielded by N 
lone pair  
staggered conformation of 
N1-C7 bond observed in X-ray 
preferred conformation to avoid 
the syn-pentane repulsion  Mar. Drugs 2010, 8  
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from the aldehyde precursor 20, in which the aldehyde is apparently the adduct of an enantioselective 
Michael addition. 
Figure 5. Retrosynthetic analysis of the indolo[2,3a]quinolizidine skeleton. 
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This retro-analysis required the addition of an activated amide 22 to the unsaturated aldehyde 21, 
which has not yet been reported in the literature. To accomplish their synthetic plan, they optimized 
the enantioselective Michael addition of cinnamic aldehyde 23 and an activated indol substituted 
amide  22, using different proline derivatives as organocatalysts (Figure 6), exploring different 
solvents, temperatures, as well as various acids needed for the cyclization step of the acyliminium ion 
(Scheme 8). Dichloromethane (DCM) was the solvent of choice and yielded compounds 24a and 24b 
with full conversion at room temperature, but with low enantioselectivity (88% ee). The 
enantioselectivity was increased to 94% by lowering the temperature to 3 °C, while further cooling 
(−20 °C) resulted in only 5% conversion. The proline derivative (S)-A showed the best selectivity, 
B was less selective and less active, while C and D were inactive for this reaction. When TFA was 
used in the acid-catalyzed cyclization of the acyliminium ion, the indoloquinolidine products were 
obtained nonselectively as a 1:1 mixture. However, some selectivity of 24a over 24b was observed 
when HCl was used. It was also noted that cooling down the reaction mixture prior to the addition of 
HCl increased the selectivity up to 85:15. The optimized conditions are highlighted in Scheme 8. 
Scheme 8. Optimized one-pot, two step conditions for the synthesis of indoloquinolizidine derivatives. 
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Figure 6. Organocatalysts used for the optimization of the one-pot conditions. 
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This one-pot, two step method was applied to several aromatic α,β-unsaturated aldehydes with 
good to excellent enantioselectivity. The indolyl moiety of 22 was replaced with an electron-rich 
phenyl group, which should give direct access to the benzo[a]quinolizidine skeleton. The reaction 
between  23 and the activated amide 25, in the presence of the organocatalyst A, and subsequent 
addition of HCl, delivered the benzo[a]quinolizidines 26a and 26b with good to high enantioselectivity 
(Scheme 9). It was noted that the formation of the benzo[a]quinolizidine moiety required stronger 
acidic conditions (40 mol%) relative to the indolo[2,3a]quinolizidine (20 mol%). This is explained by 
the poorer nucleophilicity of the phenyl ring compared to the 3-indolyl moiety. 
Scheme 9. Optimized one-pot, two step synthesis of benzo[a]quinolizidine. 
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The absolute configuration of one of the benzo[a]quinolizidine derivatives was established by X-ray 
analysis as 2R,3S,11bS, which provided important mechanistic insight (Scheme 10). The aryl groups in 
the catalyst will shield the Re face of the iminium intermediate 27, which will help to establish the 
S  configuration on C-2 through the unshielded Si face. Intramolecular imine formation with 
epimerization of the stereochemically labile stereogenic center at C-3 will establish the more 
thermodynamically stable 2R,3S-trans configuration of the intermediate imine 28. This acyliminium 
ion undergoes an electrophilic aromatic substitution with the aromatic moiety to give 
quinolizidine products. 
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Scheme 10. Proposed mechanism for the one-pot formation of quinolizidine moiety. 
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The great diastereoselectivity observed in the acid catalyzed cyclization could be explained based 
on the reaction conditions. Considering the synthesis of indoloquinolizidines  24a and 24b  
(Scheme 11), the major isomer was 24a with the indolyl moiety in an axial orientation. Although the 
formation of 24a resembles a higher energy product, reaction via the transition state I (Scheme 11) is 
under kinetic control (−78 °C), owing to less steric hindrance from the equatorial α protons relative to 
the theromodynamic equatorial product. 
Scheme 11. Kinetic versus thermodynamic product formation in the cyclization of the 
acyliminium ion. 
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As a possible application of this one-pot method in the total synthesis of biologically active marine 
alkaloids, the tricyclic core of schulzenine alkaloids could be easily constructed using Franzen and 
Fisher’s method (Figure 7). Schulzenine alkaloids were recently isolated from the marine sponge Mar. Drugs 2010, 8  
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Penares schulzei [29]. Schulzenine A–C inhibits α-glucosidase with IC50 values of 48–170 nM. Figure 8 
represents the proposed one-pot reaction that could be used for the synthesis of the tricyclic core of 
schulzenine alkaloids. 
Figure 7. Schulzenine alkaloids. 
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Schulzenine A: H-11b is α; R1 = H; R2 = CH3. 
Schulzenine B: H-11b is β; R1 = R2 = H. 
Schulzenine C: H-11b is α; R1 = R2 = H. 
Figure 8. Proposed one-pot synthesis of the tricyclic core of Schulzenine alkaloids. 
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3.3. One-pot enantioselective synthesis of pyrrolidine, hexahydropyrrolizine and related moieties 
Recently, organocatalysis has been widely used in asymmetric synthesis due to its operational 
simplicity, low toxicity and ready availability compared to metal catalyzed reactions [30]. Maruoka 
and coworkers have used an organocatalyst of type (S)-34 for one-pot construction of pyrrolidine, 
hexahydropyrrolizine and octahydroindolizine moieties with a high degree of stereoselectivity [31]. 
These core structures are commonly found in plant and marine alkaloids (Figure 9)[32,33]. Their 
organocatalytic based retro-synthetic analysis is presented in Scheme 12. 
Figure 9. Marine alkaloids that possess hexahydropyrrolizine and octahydroindolizine moieties. 
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Scheme 12. Organocatalytic retro-synthetic approach for the alkaloid core. 
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The key strategy is based on the asymmetric conjugate addition of the Schiff base of glycine ester 
32 to α,β-unsaturated carbonyl compound 33 catalyzed by the chiral phase transfer organocatalyst  
(S)-34a–c. The organocatalytic Michael addition of 32 to 33 should deliver the adduct 31 in 
enantiomerically pure form. This adduct can then undergo intramolecular reductive amination 
facilitated by the Hantzsch ester to yield the pyrrolidine derivative 30 as an intermediate. Acetal 
hydrolysis followed by another intramolecular reductive amination of the intermediate 30 will furnish 
a bicyclic hexahydropyrrolizine skeleton.  
First, the asymmetric addition of the glycine derivative 32 to methyl vinyl ketone (MVK), under the 
influence of an organocatalyst of type 34 (Scheme 13), was examined. Optimization of the reaction 
between 32 and MVK with K2CO3 and 10 mol% of CsCl at 0 °C gave the conjugate adduct 35. This 
revealed that Et2O and the organocatalyst (S)-34b gave the best yield (85%), as well as the best 
diastereoselectivity (94% ee). Subsequently, optimization of the intramolecular reductive amination of 
35 with the Hantzsch ester for the synthesis of the substituted pyrrolidine 36  was studied. The Mar. Drugs 2010, 8  
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optimization process revealed that the Hantzsch ester (2 eq.) and trifloroacetic acid (1 eq.) in aqueous 
EtOH at 60 °C were the best conditions to build up the 2,5-disubstituted cis-pyrrolidine  36 
stereospecifically in 84% yield.  
Scheme 13. Optimized conditions for the conjugate addition and intramolecular amination 
steps in the synthesis of 2,5-disubstituted cis-pyrrolidine 36. 
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Next, the synthesis of the octahydroindolizine skeleton 39 using their optimized conditions 
(Scheme 14) was performed. Asymmetric conjugate addition of the glycine ester 32 to the enone 37 
(2 eq.) and K2CO3 (5 eq.) under the influence of chiral phase transfer catalyst (S)-34b and CsCl in 
Et2O at 0 °C for 15 h gave the conjugate adduct 38 in 88% yield with 94% ee. Hantzsch ester mediated 
intramolecular reductive amination with subsequent acetal hydrolysis, followed by reductive 
amination, was effective to deliver the octahydroindolizine core 39 in 70% yield. The whole reaction 
sequence was done in a one-pot approach and performed without any difficulty by sequential addition 
of the reagents to afford 39 in 48% overall yield. 
Scheme 14. Synthesis of Octahydroindolizine 39. 
 
Hexahydropyrrolizine 42 was also obtained by the same optimized conditions (Scheme 15). The 
asymmetric conjugate addition of 32 to the enone 40 using their optimized conditions yielded adduct 
41 in 85% yield with 90% ee. It was noted that the enantioselectivity was slightly decreased by 
switching the cyclic acetal moiety of 38 to a 1,3-dioxolane (78% yield, 86% ee). The 
hexahydropyrrolizine skeleton 42 was then delivered in 55% yield by the action of Hantzsch ester 
mediated intramolecular reductive amination. The one-pot reaction was also possible with an overall 
yield of 31%. Mar. Drugs 2010, 8  
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Scheme 15. Synthesis of Hexahydropyrrolizine 42. 
 
3.4. One-pot diastereoselective synthesis of γ-lactams 
The cycloaddition of imines with succinic anhydride in a one-pot approach to construct the γ-lactam 
moiety in high yield was first reported three decades ago by Castagnoli et al. [34](Scheme 16, 
Equation 1). A mechanistic study was not published until 1983 when Cushman studied the electronic 
and steric effects on the stereochemical outcome [35]. A low yield was obtained when phenyl 
substituted succinic anhydride was used instead of succinic anhydride (Scheme 16, Equation 2). Also, 
variations in the structure of the succinic anhydride were not explored in detail in this methodology. 
Due to the wide abundance of the γ-lactam moiety in natural products and potential drug leads, the 
Shaw group has extensively studied the effect of substituents on the iminolysis of succinic anhydride 
derivatives. In their first report, Shaw and coworkers demonstrated the importance of electronic factors 
on the reactivity of phenylsuccinic anhydride when reacted with the imines derived from benzaldehyde 
and o-bromobenzaldehyde [36], demonstrating that the electron withdrawing groups in the phenyl ring 
give excellent yields (>90%)(Scheme 16, Equation 3). Following this yield improvement, Shaw and 
coworkers reported that sulfur-substituted succinic anhydrides also gave excellent yields (90%) and 
showed the highest diastereoselectivity (anti diastereoisomer) when reacted with different imines [37] 
(Scheme 16, Equation 4). 
In the case of the iminolysis of maleic anhydride, a possible zwitterionic enolate intermediate could 
be generated through a prototropic shift which provides allylic stabilization. To validate this, Shaw and 
coworkers studied the cyclization of several polycyclic imines with maleic anhydride derivatives 
(Figure 10) as a new one-pot synthesis of complex nitrogen heterocycles [38]. Thus, the reaction of the 
imine 45 with maleic anhydride derivative 46 formed intermediate 47, which could isomerize to 48. 
Attack of the α- or γ- positions of the dienolate would lead to products 49a or 49b (Scheme 17). 
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Scheme 16. Milestones of the one-pot synthesis of γ-lactam moiety. 
 
Castagnoli, et al. 1969 [34] 
 
 
Cushman, et al. 1983 [35] 
 
 
Shaw, et al. 2006 [36] 
 
 
Shaw, et al. 2007 [37] 
  
Equation 4 
Equation 3 
Equation 2 
Equation 1  
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Figure 10. Imines and substituted maleic anhydrides used by Shaw et al. [38]. 
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Scheme 17. Possible cycloaddition pathways of imines with maleic anhydrides. 
 
Tetrahydrophthalic anhydride 44b reacted with several imines through path A to give the formal 
cycloaddition products with high diastereoselectivity (anti configuration) and acceptable yields 
(Scheme 18, Equations 1 and 2). It was interesting that the diastereoselectivity of the reaction of 44b 
with 43b was reversed when triethylamine and triethylammonium hydrochloride were present in the 
reaction mixture. Methyl and dimethyl-substituted anhydrides did not react with several imines; 
however, an exomethylene-substituted lactam was obtained in good yield (59%) with excellent 
diastereoselectivity (>95:5 anti:syn) when imine 43b was used (Scheme 18, Equation 3). Acyclic 
imines derived from aromatic aldehydes were less reactive relative to cyclic imines. 
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Scheme 18. Polycyclic products from the reactions of anhydrides 44b and 44c with different imines. 
 
 
 
Although the 
1H-NMR spectrum of the products obtained from the reaction of cyclopentane-fused 
maleic anhydride 44a with several imines initially appeared to be consistent with the anticipated 
adduct, X-ray crystallographic analysis revealed the products to be N,O-acetals (Scheme 19). Mixing 
the anhydride 44a with the imines 43a and 43b at room temperature yielded an immediate precipitate 
of N,O-acetals 53 and 54 in 78% and 71% yields respectively. No γ-lactam products were produced 
upon further heating. 
Scheme 19. Reaction of anhydride 44a with several imines to yield N,O-acetal products. 
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A completely different reaction manifold was observed in the reaction of ketimine 43c with the 
maleic anhydride derivative 44c (Scheme 20). A new γ-lactam product was obtained. The mechanism 
of formation of this new product is outlined in Scheme 20. A Prototropic shift of acylated imine 55 
will yield the enamide carboxylic acid 56, which is setup for an intramolecular Michael-type addition 
of the enamide to the unsaturated acid to deliver a new lactam 58 through enamide 57. 
Equation 3 
Equation 2 
Equation 1 Mar. Drugs 2010, 8  
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Scheme 20. Mechanism of the formation of a new γ-lactam product obtained from the 
reaction of the ketimine 43c with anhydride 44c. 
Anhydrides 44d and 44b reacted similarly with ketimine 43c to produce new γ-lactam products 59 
and 60, in yields of 74% and 59% respectively (Scheme 21). In the case of the spiro γ-lactam 60, a 
50:50 mixture of diastereoisomers was obtained after 15 min of reaction time. Continued heating of 60 
under the reaction conditions shifted the diastereoselectivity to a 70:30 mixture, favoring the anti 
isomer. Product 61 was obtained in 72% yield when anhydride 44a was reacted with ketimine 43c. No 
stereoselectivity was observed in this case. 
Scheme 21. New γ-lactam products obtained from the reaction of the ketimine 43c with 
several anhydrides. 
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4. Conclusion 
In this mini-review, we have highlighted a number of one-pot asymmetric methodologies developed 
for the synthesis of important alkaloid moieties. One-pot reactions are highly practical and ideal for 
scaling drug leads to gram scale and greater. The manzamine alkaloids are still providing inspiration 
for new chemistry in which one-pot methodologies are being developed and will be discussed in 
separate reports. We anticipate a greater application of these methods and similar methodologies in the 
field of total synthesis of marine alkaloids and have highlighted the possible route to the schulzenine 
alkaloids. Two or more methodologies could be combined to design a complete synthesis of a 
particular target. The alkaloid moieties highlighted in this mini-review (i.e., substituted piperidines, 
quinolizidines, pyrrolidines, hexahydropyrrolizines, octahydroindolizines and γ-lactams) are common 
within the alkaloid family. Although there are many methods for the synthesis of these moieties, the 
development of one-pot methodologies to obtain high yields with a high degree of enantioselectivity 
will provide numerous opportunities for the synthetic community.  
Acknowledgments  
The authors would like to thank DOD, NIAID and the NIH National Center for Research Resources 
project, Grant Numbers 5P20RR021929, C06 RR-14503-01 for the financial support. The content is 
solely the responsibility of the authors and does not necessarily represent the official views of the 
National Center for Research Resources or the National Institutes of Health. A.E.W. gratefully thanks 
The Ministry of Higher Education of Egypt for a predoctoral fellowship. 
References 
1.  Peng, J.; Rao, K.V.; Choo, Y.M.; Hamann, M.T. Manzamine alkaloids. In Modern Alkaloids; 
Fattorusso, E., Taglialatela-Scafati, O., Eds.; Wiley-VCH Verlag GmbH & Co. KgaA: Weinheim, 
Germany, 2007; pp. 189–232. 
2.  Tietze, L.F. Domino reactions in organic synthesis. Chem. Rev. 1996, 96, 115–136. 
3.  Tietze, L.F.; Beifuss, U. Sequential transformations in organic chemistry: A synthetic strategy 
with a future. Angew. Chem. Int. Ed. Engl. 1993, 32, 131–163. 
4.  Nicolaou, K.C.; Montagnon, T.; Snyder, S.A. Tandem reactions, cascade sequences, and 
biomimetic strategies in total synthesis. Chem. Commun. 2003, 5, 551–564. 
5.  Nicolaou, K.C.; Edmonds, D.J.; Bulger, P.G. Cascade reactions in total synthesis. Angew. Chem. 
Int. Ed. Engl. 2006, 45, 7134–7186. 
6.  Nicolaou, K.C.; Chen, S.J. The art of total synthesis through cascade reactions. Chem. Soc. Rev. 
2009, 38, 2993–3009. 
7.  Pellissier, H. Asymmetric domino reactions. Part A: reactions based on the use of chiral 
auxiliaries. Tetrahedron 2006, 62, 1619–1665. 
8.  Pellissier, H. Asymmetric domino reactions. Part B: reactions based on the use of chiral catalysts 
and biocatalysts. Tetrahedron 2006, 62, 2143–2173. 
9.  Padwa, A. Domino reactions of rhodium(ii) carbenoids for alkaloid synthesis. Chem. Soc. Rev. 
2009, 38, 3072–3081. Mar. Drugs 2010, 8  
 
 
2415
10.  Padwa, A.; Bur, S.K. The domino way to heterocycles. Tetrahedron 2007, 63, 5341–5378. 
11.  Kibayashi, C. Development of new synthetic methods and its applications to total synthesis of 
nitrogen-containing bioactive natural products. Chem. Pharm. Bull. 2005, 53, 1375–1386.  
12.  Sakai. R.; Higa, T.; Jefford, C.W.; Bernardinelli, G. Manzamine A, a novel antitumor alkaloid 
from a sponge. J. Am. Chem. Soc. 1986, 108, 6404–6405. 
13.  Rao, K.V.; Kasanah, N.; Wahyuono, S.; Tekwani, B.L.; Schinazi, R.F.; Hamann, M.T. Three new 
manzamine alkaloids from a common Indonesian sponge and their activity against infectious and 
tropical parasitic diseases. J. Nat. Prod. 2004, 67, 1314–1318. 
14.  Peng, J.; Kudrimoti, S.; Prasanna, S.; Odde, S.; Doerksen, R.J.; Pennaka, H.K.; Choo, Y.; Rao, 
K.V.; Tekwani, B.L.; Madgula, V.; Khan, S.I.; Wang, B.; Mayer, A.M.S.; Jacob, M.R.; Tu., L.C.; 
Gertsch, J.; Hamann. M.T. Structure-activity relationship and mechanism of action studies of 
manzamine analogues for the control of neuroinflammation and cerebral infections. J. Med. 
Chem. 2010, 53, 61–76. 
15. Wahba, A.E.; Peng, J.; Kudrimoti, S.; Tekwani, B.L.; Hamann, M.T. Structure activity 
relationship studies of manzamine A: amidation of positions 6 and 8 of the β-carboline moiety. 
Bioorg. Med. Chem. 2009, 17, 7775–7782. 
16.  Shilabin, A.G.; Kasanah, N.; Tekwani, B.L.; Hamann, M.T. Kinetic studies and bioactivity of 
potential manzamine prodrugs. J. Nat. Prod. 2008, 71, 1218–1221. 
17.  El Sayed, K.A.; Khalil, A.A.; Yousaf, M.; Labadie, G.; Kumar, G.M.; Franzblau, S.G.; Mayer, 
A.M.S.; Avery, M.A.; Hamann, M.T. Semisynthetic studies on the manzamine alkaloids . J. Nat. 
Prod. 2008, 71, 300–308. 
18.  Ibrahim, M.A.; Shilabin, A.G.; Prasanna, S.; Jacob, M.; Khan, S.I.; Doerksen, R.J.; Hamann, M.T. 
2-Methyl modifications and SAR studies of manzamine A. Bioorg. Med. Chem.  2008,  16,  
6702–6706. 
19.  Wahba, A.E.; Peng, J.; Hamann, M.T. Reductive amidation of nitroarenes: a practical approach 
for the amidation of natural products. Tetrahedron Lett. 2009, 50, 3901–3904. 
20. De Oliveira, J.H.H.L.; Nascimento, A.M.; Kossuga, M.H.; Cavalcanti, B.C.; Pessoa, C.O.; 
Moraes, M.O.; Macedo, M.L.; Ferreira, A.G.; Hajdu, E.; Pinheiro, U.S.; Berlinck, R.G.S. 
Cytotoxic alkylpiperidine alkaloids from the Brazilian marine sponge pachychalina alcaloidifera. 
J. Nat. Prod. 2007, 70, 538–543. 
21.  Matsunaga, S.; Miyata, Y.; van Soest, R.W.M.; Fusetani, N. Tetradehydrohalicyclamine A and 
22-hydroxyhalicyclamine A, new cytotoxic bis-piperidine alkaloids from a marine sponge 
amphimedon sp. J. Nat. Prod. 2004, 67, 1758–1760. 
22.  Ishiguro, Y.; Kubota, T.; Ishiuchi, K.; Fromont, J.; Kobayashi, J. Plakoridine C, a novel piperidine 
alkaloid from an Okinawan marine sponge Plakortis sp. Tetrahedron Lett. 2009, 50, 3202–3204. 
23.  Escolano, C.; Amat, M.; Bosch, J. Chiral Oxazolopiperidone Lactams: Versatile Intermediates for 
the Enantioselective Synthesis of Piperidine-Containing Natural Products. Chem. Eur. J. 2006, 12, 
8198–8207. 
24.  Felpin, F.; Lebreton, J. Recent advances in the total synthesis of piperidine and pyrrolidine natural 
alkaloids with ring-closing metathesis as a key step. Eur. J. Org. Chem. 2003, 2003, 3693–3712. 
25. Laschat, S.; Dickner, T. Stereoselective synthesis of piperidines. Synthesis  2000,  2000,  
1781–1813. Mar. Drugs 2010, 8  
 
 
2416
26.  Sun, X.; Sengupta, S.; Petersen, J.L.; Wang, H.; Lewis, J.P.; Shi, X. Intermolecular cross-double-
Michael addition between nitro and carbonyl activated olefins as a new approach in C-C bond 
formation. Org. Lett. 2007, 9, 4495–4498. 
27.  Chen, Y.; Zhong, C.; Petersen, J.L.; Akhmedov, N.G.; Shi, X. One-pot asymmetric synthesis of 
substituted piperidines by exocyclic chirality induction. Org. Lett. 2009, 11, 2333–2336. 
28. Franzen, J.; Fisher, A. Asymmetric alkaloid synthesis: a one-pot organocatalytic reaction to 
quinolizidine derivatives. Angew. Chem. Int. Ed. Engl. 2009, 48, 787–791. 
29.  Takada, K.; Uehara, T.; Nakao, Y.; Matsunaga, S.; van Soest, R.W.; Fusetani, N. Schulzeines  
A-C, new α-glucosidase inhibitors from the marine sponge penares schulzei. J. Am. Chem. Soc. 
2004, 126, 187–193. 
30.  Enders, D.; Grondal, C.; Huttl, A.R.M. Asymmetric organocatalytic domino reactions. Angew. 
Chem. Int. Ed. Engl. 2007, 46, 1570–1581. 
31.  Wang, Y.; Kumano, T.; Kano, T.; Maruoka, K. Organocatalytic approach to enantioselective   
one-pot synthesis of pyrrolidine, hexahydropyrrolizine, and octahydroindolizine core structures. 
Org. Lett. 2009, 11, 2027–2029. 
32. El-Naggar, M.; Piggott, A.M.; Capon, R.J. Bistellettazines A-C and Bistellettazole A: New 
Terpenyl-Pyrrolizidine and Terpenyl-Imidazole Alkaloids from a Southern Australian Marine 
Sponge, Stelletta sp. Org. Lett. 2008, 10, 4247–4250. 
33.  Biard, J.F.; Guyot, S.; Roussakis, C.; Verbist, J.F.; Vercauteren, J.; Weber, J.F.; Boukef, K. 
Lepadiformine, a new marine cytotoxic alkaloid from Clavelina lepadiformis Mueller. 
Tetrahedron Lett. 1994, 35, 2691–2694. 
34. Castagnoli, N.J. N-Acylenamines from oxazolines. New route to 2-acetamidogylcals. J. Org. 
Chem. 1969, 34, 3187–3189. 
35.  Cushman, M.; Abbaspour, A.; Gupta, Y.P. Total synthesis of (±)-14-epicorynoline,   
(±)-corynoline, and (±)-6-oxocorynoline. J. Am. Chem. Soc. 1983, 105, 2873–2879. 
36. Masse, C.E.; Ng, P.Y.; Fukase, Y.; Sanchez-Rosello, M.; Shaw, J.T. Divergent Structural 
Complexity from a Linear Reaction Sequence: Synthesis of Fused and Spirobicyclic γ-Lactams 
from Common Synthetic Precursors. J. Comb. Chem. 2006, 8, 293–296. 
37.  Wei, J.; Shaw, J.T. Diastereoselective Synthesis of γ-Lactams by a One-Pot, Four-Component 
Reaction. Org. Lett. 2007, 9, 4077–4080. 
38.  Tang, Y.; Fettinger, J.C.; Shaw, J.T. One-Step Synthesis of Complex Nitrogen Heterocycles from 
Imines and Alkyl-Substituted Maleic Anhydrides. Org. Lett. 2009, 11, 3802–3805. 
Samples Availability: Available from the authors. 
© 2010 by the authors; licensee MDPI, Basel, Switzerland. This article is an Open Access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 